Zhao X - Search Results

1

The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgery.

Zhang L, Zhang H, Yue D, Wei W, Chen Y, Zhao X, Zhu J, Zhang B, Zhang Z, Wang C. Zhang L, et al. Among authors: zhao x. Thorac Cancer. 2019 Jul;10(7):1581-1589. doi: 10.1111/1759-7714.13107. Epub 2019 Jun 3. Thorac Cancer. 2019. PMID: 31161711 Free PMC article.

2

Do tumor cavitation and sex in resected stage I non-small-cell lung cancer correlate with prognosis?

Wang M, Zhao J, Pan Y, Su YJ, You J, Zhao XL, Wang CL. Wang M, et al. World J Surg. 2009 Mar;33(3):497-504. doi: 10.1007/s00268-008-9859-3. World J Surg. 2009. PMID: 19115028

3

The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis.

Wang C, Su Y, Zhang L, Wang M, You J, Zhao X, Zhang Z, Liu J, Hao X. Wang C, et al. Among authors: zhao x. PLoS One. 2012;7(9):e38046. doi: 10.1371/journal.pone.0038046. Epub 2012 Sep 26. PLoS One. 2012. PMID: 23049725 Free PMC article.

4

Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer.

Wang M, Zhao J, Su YJ, Zhao XL, Wang CL. Wang M, et al. Oncol Lett. 2012 Dec;4(6):1349-1353. doi: 10.3892/ol.2012.892. Epub 2012 Sep 3. Oncol Lett. 2012. PMID: 23226806 Free PMC article.

5

Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer.

Hao L, Zhao X, Zhang B, Li C, Wang C. Hao L, et al. Among authors: zhao x. Tumour Biol. 2015 Mar;36(3):1811-7. doi: 10.1007/s13277-014-2784-1. Epub 2014 Nov 7. Tumour Biol. 2015. PMID: 25377161

6

[Cetuximab in combination with icotinib overcomes the acquired resistance caused by EGFR T790M mutation in non-small cell lung cancer].

Wang M, Zhang L, Zhao X, Liu J, Chen Y, Wang C. Wang M, et al. Among authors: zhao x. Zhonghua Zhong Liu Za Zhi. 2014 Sep;36(9):651-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25564053 Chinese.

7

Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects.

Zhao X, Su Y, You J, Gong L, Zhang Z, Wang M, Zhao Z, Zhang Z, Li X, Wang C. Zhao X, et al. Among authors: zhao z. Oncotarget. 2016 Sep 20;7(38):62619-62626. doi: 10.18632/oncotarget.11547. Oncotarget. 2016. PMID: 27566586 Free PMC article. Clinical Trial.

8

Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors.

Zhao X, Wen X, Wei W, Chen Y, Zhu J, Wang C. Zhao X, et al. Oncotarget. 2017 Jul 11;8(28):46491-46497. doi: 10.18632/oncotarget.14822. Oncotarget. 2017. PMID: 28148889 Free PMC article.

9

Predictors for the efficacy of Endostar combined with neoadjuvant chemotherapy for stage IIIA (N2) NSCLC.

Zhao X, Wen X, Wei W, Su Y, You J, Gong L, Zhang Z, Wang M, Xiao J, Wei X, Wang C. Zhao X, et al. Cancer Biomark. 2017 Dec 12;21(1):169-177. doi: 10.3233/CBM-170565. Cancer Biomark. 2017. PMID: 29036790 Clinical Trial.

10

Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?

Zhao X, McCutcheon JN, Kallakury B, Chahine JJ, Pratt D, Raffeld M, Chen Y, Wang C, Giaccone G. Zhao X, et al. J Thorac Oncol. 2018 Feb;13(2):237-245. doi: 10.1016/j.jtho.2017.10.010. Epub 2017 Oct 31. J Thorac Oncol. 2018. PMID: 29101056 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,094 results

Search Page

Filters